Meroven LLC and CURE Pharmaceutical Enter Exclusive Marketing and Distribution Agreement for Spee-D for the USA
02 mai 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
CHICAGO, May 02, 2019 (GLOBE NEWSWIRE) -- Today, at the CPhI Conference, Meroven LLC announced a five-year agreement with CURE Pharmaceutical Corporation (OTCQB: CURR) to exclusively market and...